Cell No. : Cell Name
RCB1872 : A431
update : 2024/08/14
|
| Comment | Human cell line derived from epidermoid carcinoma. TKG0182 (Deposited from Tohoku Univ.). |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Obinata, Masuo
|
| Originator |
Giard D J, Aaronson S A
|
| Year of deposit |
2004
|
| Original cell |
TKG0182
|
| Animal |
_human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Gender |
Female
|
| Age at sampling |
85 years
|
| Tissue |
epidermoid carcinoma
|
| Classification |
cancer
|
| History |
Cell Resource Center for Biomedical Research, Tohoku University（TKG0182）
|
|
Lifespan |
infinite
|
| Morphology |
epithelial-like
|
| Cellosaurus(Expasy) |
CVCL_0037
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Culture medium |
|
RPMI1640 + 10% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
| SC frequency |
|
Subculture : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma |
|
(-)
|
| Isozyme |
|
LD, NP
|
| STR(human) |
|
OK
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
5
|
| User's Publication |
6
|
| Reference |
|
155
Todaro GJ, Fryling C, De Larco JE.
Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors
Proc Natl Acad Sci U S A
1980
77(9):5258-62
PubMed ID: 6254071
DOI: 10.1073/pnas.77.9.5258
|
|
156
J E De Larco, G J Todaro
Sarcoma growth factor: specific binding to and elution from membrane receptors for epidermal growth factor
Cold Spring Harb Symp Quant Biol
1980
44 Pt 1,:643-9
PubMed ID: 6253166
DOI: 10.1101/sqb.1980.044.01.067
|
|
157
De Larco JE, Todaro GJ.
Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors
J Cell Physiol
1980
102(2):267-77.
PubMed ID: 6246130
DOI: 10.1002/jcp.1041020218
|
|
153
Todaro GJ, De Larco JE.
Growth factors produced by sarcoma virus-transformed cells
Cancer Res
1978
38(11 Pt 2):4147-54
PubMed ID: 212188
|
|
1026
Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP.
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.
J Natl Cancer Inst
1973
51(5):1417-23
PubMed ID: 4357758
DOI: 10.1093/jnci/51.5.1417
|
| User's Publication |
|
13770
Kim H, Hoshi M, Iijima M, Kuroda S, Nakamura C.
Development of a universal method for the measurement of binding affinities of antibody drugs towards a living cell based on AFM force spectroscopy
Anal Methods
2020
12(22):2922-2927
PubMed ID: 32930215
DOI: 10.1039/d0ay00788a
|
|
11376
Ren Q, Mohri K, Warashina S, Wada Y, Watanabe Y, Mukai H.
Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab.
Mol. Pharm.
2019
PubMed ID: 30633529
DOI: 10.1021/acs.molpharmaceut.8b01052
|
|
4872
Tanaka H, Sakagami H, Kaneko N, Konagai S, Yamamoto H, Matsuya T, Yuri M, Yamanaka Y, Mori M, Takeuchi M, Koshio H, Hirano M, Kuromitsu S.
Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression.
Mol Cancer Ther
2019
18(8):1366-1373
PubMed ID: 31092564
DOI: 10.1158/1535-7163.MCT-18-0976
|
|
12217
Mio Matsui, Kosuke Tanaka, Naoki Higashiguchi, Hisato Okawa, Yoichi Yamada, Ken Tanaka, Soichiro Taira, Tomoko Aoyama, Misaki Takanishi, Chika Natsume, Yuuki Takakura, Norihisa Fujita, Takeshi Hashimoto, Takashi Fujita
Protective and therapeutic effects of fucoxanthin against sunburn caused by UV irradiation
J Pharmacol Sci
2016
132(1):55-64
PubMed ID: 27590588
DOI: 10.1016/j.jphs.2016.08.004
|
|
15024
Thang ND, Yajima I, Ohnuma S, Ohgami N, Kumasaka MY, Ichihara G, Kato M.
Enhanced constitutive invasion activity in human nontumorigenic keratinocytes exposed to a low level of barium for a long time
Environ Toxicol
2015
30(2):161-7
PubMed ID: 23804419
DOI: 10.1002/tox.21881
|
|
6114
Thang ND, Yajima I, Kumasaka MY, Ohnuma S, Yanagishita T, Hayashi R, Shekhar HU, Watanabe D, Kato M.
Barium promotes anchorage-independent growth and invasion of human HaCaT keratinocytes via activation of c-SRC kinase.
PLoS One
2011
6(10):e25636
PubMed ID: 22022425
DOI: 10.1371/journal.pone.0025636
|
Back
Top
CELL BANK Website
